Phorbol ester facilitates transmitter release at a variety of synapses, and the phorbol ester-induced synaptic potentiation (PESP) is a model for presynaptic facilitation. To address the mechanism underlying PESP, we have made paired whole-cell recordings from the giant presynaptic terminal, the calyx of Held, and its postsynaptic target in the medial nucleus of the trapezoid body in rat brainstem slices. Phorbol ester potentiated EPSCs without affecting either presynaptic calcium currents or potassium currents. Protein kinase C inhibitors applied from outside or injected directly into the presynaptic terminal attenuated the PESP. Furthermore, presynaptic loading of a synthetic peptide with the sequence of the N-terminal domain of Doc2␣ interacting with Munc13-1 (Mid peptide) significantly attenuated PESP, whereas mutated Mid peptide had no effect. We conclude that the target of the presynaptic facilitatory effect of phorbol ester resides downstream of calcium influx and may involve both protein kinase C and Doc2␣ -Munc13-1 interaction.
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Key words: phorbol ester; synaptic facilitation; Doc2␣; Munc13-1; protein kinase C; the calyx of Held; presynaptic recording
Phorbol ester enhances synaptic efficacy by increasing transmitter release at a variety of synapses (Malenka et al., 1986; Shapira et al., 1987) . This presynaptic facilitatory effect of phorbol ester is thought to be mediated by protein kinase C (PKC) through (1) activation of calcium channels (Fossier et al., 1990; O'Dell and Alger, 1991; Parfitt and Madison, 1993; Swartz et al., 1993; Stea et al., 1995) , (2) inhibition of potassium channels (Barban et al., 1985; Storm, 1987; Doerner et al., 1988; Hoffman and Johnston, 1998) , or (3) activation of exocytotic machinery downstream of Ca 2ϩ influx (C apogna et al., 1995; Redman et al., 1997) . However, there is no direct evidence to indicate which, if any, of the above targets are involved in the phorbol ester-induced synaptic potentiation (PESP). Furthermore, an involvement of PKC in the PESP has been questioned recently at some synapses, where certain PKC inhibitors had no effect on the PESP (Redman et al., 1997) . It has been reported that Munc13-1, a mammalian homolog of Caenorhabditis elegans unc13p, has a diacylglycerol (DAG) receptor similar in affinity to PKC and is localized in the plasma membrane near the release site (Betz et al., 1998) . Munc13-1 interacts with the vesicular protein Doc2␣ in a DAGor phorbol ester-dependent manner (Orita et al., 1997) . A possible involvement of Munc13-1 in PESP has been suggested at the amphibian neuromuscular junction in cell culture, where overexpression of Munc13-1 augmented the PESP (Betz et al., 1998) .
The caly x of Held in the rodent auditory brainstem is a giant glutamatergic nerve terminal of anterior ventral cochlear neuron forming synapse onto the somata of principal cells of medial nucleus of trapezoid body (M N TB) (Barnes-Davies and Forsythe, 1995) . Because of its large size, it is possible to make direct whole-cell recordings from the nerve terminal (Forsythe, 1994; Borst et al., 1995; Takahashi et al., 1996) and also to load molecules directly into it through a patch pipette . Taking advantage of this preparation, we have studied the mechanism underlying PESP. Our results indicate that neither calcium nor potassium conductances are involved in the presynaptic effect of phorbol ester, suggesting an involvement of the mechanism downstream of Ca 2ϩ influx. By directly injecting the N-terminal peptide fragment of Doc2␣ or the PKC inhibitor peptide into the calyceal nerve terminal, we have demonstrated that the Doc2␣-Munc13-1 interaction as well as the PKC activation may mediate the PESP.
MATERIALS AND METHODS
Preparation and solutions. Transverse slices of the superior olivary complex were prepared from 14-to 16-d-old Wistar rats killed by decapitation under halothane anesthesia. The M N TB neurons and calyces were viewed with a 60ϫ (Olympus Optical, Tokyo, Japan) water immersion lens attached to an upright microscope (Axioskop; Z eiss). Each slice was superf used with artificial C SF (aC SF) containing (in mM): 120 NaC l, 2.5 KC l, 26 NaHC O 3 , 1.25 NaH 2 PO 4 , 2 CaCl 2 , 1 MgC l 2 , 10 glucose, 0.5 myo-inositol, 2 sodium pyruvate, and 0.5 ascorbic acid, pH 7.4, with 5% CO 2 and 95% O 2 . For recording EPSC s, the aC SF contained routinely bicuculline methiodide (10 M) and strychnine hydrochloride (0.5 M) to block spontaneous inhibitory synaptic currents. Effect of phorbol ester on EPSC s was tested in the aC SF containing 1 mM [C a 2ϩ ] and 2 mM [Mg 2ϩ ]. For recording presynaptic C a 2ϩ currents, 10 mM tetraethylammonium (TEA) chloride and 1 M tetrodotoxin (TTX) were included in the aC SF. For recording presynaptic K ϩ current or spontaneous mEPSC s, 1 M TTX was included in the aC SF. For recording presynaptic action potentials, presynaptic pipettes were filled with the solution containing (in mM): 97.5 potassium gluconate, 32.5 KC l, 10 H EPES, 0.2 EGTA, 1 MgC l 2 , 10 potassium glutamate, 2 ATP (Mg salt), 12 phosphocreatine, and 0.5 GTP, pH 7.4 adjusted with KOH. For recording presynaptic C a 2ϩ currents, potassium gluconate and KC l in the presynaptic pipette solution were replaced by 110 mM CsCl, 10 mM TEA chloride was added, and H EPES concentration was increased to 40 mM, pH 7.4 adjusted with C sOH. For postsynaptic recordings, pipette solution contained (in mM): 110 C sF, 30 C sC l, 10 H EPES, 5 EGTA, and 1 MgC l 2 .
When the aC SF did not contain TTX, N-(2,6-diethylphenylcarbamoylmethyl)-triethylammonium bromide (QX314; 5 mM) was included in the postsynaptic pipette solution to suppress action potential generation.
Data recording and anal ysis. Whole-cell patch-clamp recordings were made from M N TB principal neurons, presynaptic calyces, or simultaneously from both structures. EPSC s were evoked at 0.1 Hz throughout by extracellular stimulation of presynaptic axons using a bipolar platinum electrode positioned near the midline of a relatively thick slice (200 m) or by presynaptic action potentials elicited directly by a whole-cell pipette in thin slices (150 m). The resistance of patch pipette was 4 -7 M⍀ for presynaptic recordings and 2-4 M⍀ for postsynaptic recordings. The series resistance of presynaptic recording was typically 10 -20 M⍀ and was compensated by 70 -90% in voltage-clamp experiments. Current or potential recordings were made with a patch-clamp amplifier (Axopatch 200B; Axon Instruments, Foster C ity, CA). Records were low-passfiltered at 2.5-20 kHz and digitized at 5-50 kHz by a CED 1401 interface (C ambridge Electronic Design). Presynaptic voltage-gated currents were leak-subtracted by using a scaled pulse divided by n (P/ N) protocol (Forsythe et al., 1998; Takahashi et al., 1998) . The magnitude of potentiation of EPSC s was evaluated from the mean amplitude of six consecutive events during 5-6 min after phorbol ester application divided by that of six events before application. Values in the text and figures are given as means Ϯ SEM, and significance of difference was evaluated by one-way ANOVA or Kolmogorov-Smirnov test (for cumulative histograms) with 0.05 taken as the level of significance.
Drug application. Drugs were bath-applied by switching superf usates using solenoid valves. Peptides were injected into calyces through a superf usion tube directly installed in a presynaptic patch pipette. The superf usion tube was fabricated from an Eppendorf yellow tip heated and pulled to make an outer tip diameter of 50 -70 m. After back-filling the tube with pipette solutions containing synthetic peptides, it was inserted into a patch pipette with its tip 500 -600 m behind the tip of patch pipette. After obtaining control responses, the dialysis solution was delivered into presynaptic patch pipette with positive pressure manually applied through a syringe. When a fluorescence dye L ucifer yellow (0.05%) was injected by this method, fluorescence became detectable in a caly x within 1 min after injection and reached maximal intensity within 4 min. When FI TC -conjugated albumin was injected, the whole caly x was stained within 5 min. The amino acid sequence of synthetic Mid peptide and mutated Mid peptide is IQEHM AI NC PGPIRPIRQISDYFP and I YK DWAF N VC PGPIRPIRQISDYFP, respectively (Orita et al., 1997) . PKC inhibitor peptide, PKCI (19 -36), Mid peptide, or mutated Mid peptide was dissolved in pipette solution at 200 M and loaded into calyces through the superf usion tube. E xperiments were carried at room temperature (22-26°C).
RESULTS

Potentiation of EPSCs by phorbol esters
As illustrated in Figure 1 A, phorbol ester markedly potentiated the calyx-MNTB EPSCs as reported at other synapses (Malenka et al., 1986; Shapira et al., 1987) . During bath-application of phorbol 1,2-dibutrate (PDBu; 0.5 M for 2 min), EPSCs became larger reaching a maximal size within 5 min after application. The mean magnitude of this potentiation was 162 Ϯ 37% (Ϯ SEM; n ϭ 6 cells, see also Fig. 5A ). The potentiation by PDBu at this concentration lasted for Ͼ20 min with no sign of decline.
Other phorbol esters such as phorbol-12,13-diacetate or phorbol-12-myristate-13 acetate produced a similar potentiating effect (both at 0.5 M; data not shown) but the inactive 4␣-PDBu (0.5 M) had no effect (Ϫ0.8 Ϯ 9.9%; n ϭ 7; Fig. 1 B) . The potentiating effect of PDBu on EPSC s was dose-dependent ( Fig. 1C) with a maximum potentiation reached at around 0.5 M and the 50% effective dose (EC 50 ) being 121 nM with a 2 min application. Potentiation of EPSCs was transient when low doses of PDBu were applied for 2 min, but it was sustained when PDBu was continuously applied. The EC 50 of continuously applied PDBu was 75 nM.
Effects of phorbol ester on quantal EPSCs
We subsequently examined the effect of PDBu on spontaneous miniature (m) EPSC s recorded in the presence of TTX (1 M; Fig. 2 ). As shown in cumulative interval histograms, PDBu (0.5 M) increased the mean frequency of mEPSC s (6.7 Ϯ 3 Hz) on average by 2.1 Ϯ 0.5-fold (n ϭ 5; Fig. 2 A) . In contrast, neither the kinetics nor the amplitude of mEPSC s was significantly affected by PDBu (Fig. 2 B) . The mean amplitude of mEPSC s after PDBu application was 102 Ϯ 2.9% (n ϭ 6) of control before PDBu application, suggesting that this phorbol ester had no effect on postsynaptic glutamate receptor sensitivity. Thus, as reported at other synapses (Malenka et al., 1986; Shapira et al., 1987) , the site of its action must be purely presynaptic.
Lack of phorbol ester effect on presynaptic calcium currents
Previous studies on somatic or recombinant C a 2ϩ currents indicate that phorbol ester can enhance C a 2ϩ currents (Fossier et al., 1990; O'Dell and Alger, 1991; Parfitt et al., 1993; Stea et al., 1995) . It was then speculated that a similar potentiation might occur at the presynaptic nerve terminals. We have directly tested this possibility by recording the presynaptic C a 2ϩ currents from the giant nerve terminal, the caly x of Held. The C a 2ϩ currents at the caly x have been pharmacologically identified as P-type (Forsythe et al., 1998; Iwasaki and Takahashi, 1998) , and they can be attenuated by agonists of metabotropic glutamate receptors or GABA B receptors . As illustrated in Figure 3 , PDBu (0.5 M) had no effect on presynaptic C a 2ϩ currents at all membrane potential examined, with the mean magnitude of C a 2ϩ currents at Ϫ10 mV being 98 Ϯ 3% of control (n ϭ 5). These results indicate that the PESP is not mediated by presynaptic Ca 2ϩ channels, at least at this mammalian brainstem synapse.
Presynaptic potassium currents are unaffected by phorbol ester
Voltage-gated potassium channel currents in hippocampal neurons are attenuated by phorbol esters (Barban et al., 1985; Storm, 1987; Doerner et al., 1988; Hoffman and Johnston, 1998) . If phorbol ester attenuates presynaptic potassium channels, this would presumably lead to increased Ca 2ϩ influx, thereby enhancing transmitter release. We have tested this possibility by recording presynaptic potassium currents. As shown in Figure 4 , PDBu (0.5 M) had no effect on the presynaptic voltage-dependent potassium currents. The mean amplitude of potassium current at 0 mV was 4.7 Ϯ 0.4 nA in control and 4.9 Ϯ 0.5 nA after PDBu Figure 3 . Phorbol ester had no effect on presynaptic calcium currents. Voltage-dependent C a 2ϩ currents were evoked in calyceal presynaptic terminals by a depolarizing pulse from Ϫ80 mV holding potential to Ϫ10 mV before and after PDBu application (0.5 M, two traces superimposed in inset). The C a 2ϩ current-voltage relationships before (F) and 6 -9 min after (E) PDBu application. Data points and error bars are means and SEMs of C a 2ϩ current amplitude from five calyces. The mean amplitude of C a 2ϩ currents at Ϫ10 mV was 928 Ϯ 9.4 pA in control and 904 Ϯ 7.3 pA after PDBu application (n ϭ 5). Lines are drawn by eyes in this and the next figure. application (n ϭ 5). It has been also reported that G-proteincoupled inward rectif ying potassium (GIRK) conductance can be suppressed by PKC activation (Takano et al., 1995) . Although any change in GIRK can be revealed as a change in holding current , PDBu had no effect on the holding current (98.9 Ϯ 5.7%; n ϭ 5), suggesting that GIRK is not involved in the PESP. These results indicate that neither the calcium conductance nor potassium conductance in the presynaptic terminal is involved in the PESP at this synapse. Therefore, the target of phorbol ester must be downstream of C a 2ϩ influx as has been suggested for secretory cells (Gillis et al., 1996) .
Involvement of PKC in phorbol ester-induced synaptic potentiation
To address whether PKC is involved in the effect of phorbol esters, we tested a number of PKC inhibitors on PESP. Bisindolylmaleimid (BIS; 1 M), a competitive inhibitor for the ATPbinding site of PKC, partially but significantly attenuated the phorbol ester-induced synaptic facilitation (Fig. 5A) . Potentiation of EPSC s 5-6 min after application of PDBu (0.5 M) was 64 Ϯ 9.6% (n ϭ 5) in the presence of BIS, whereas it was 162 Ϯ 37% (n ϭ 6) in control (see above). C alphostin C (0.5 M), a competitive inhibitor for the phorbol ester-binding site of PKC, also significantly suppressed the PESP with the potentiation being 48 Ϯ 24% (n ϭ 3) in its presence (data not shown). A more specific tool to test an involvement of PKC is the PKC inhibitor peptide (PKCI; 19 -36), which acts as a pseudosubstrate for PKC. We injected PKCI into the calyceal presynaptic nerve terminals during paired presynaptic and postsynaptic whole-cell recordings. EPSC s were evoked by presynaptic action potentials elicited in calyceal nerve terminals with a patch pipette . In control experiments, externally applied PDBu (0.5 M) potentiated EPSC s (Fig. 5B ) with a magnitude (138 Ϯ 29%; n ϭ 5) comparable to that observed for the extracellularly evoked EPSC s (no significant difference). When PKCI was injected into the caly x, the peptide by itself had no effect on EPSC s (data not shown), but PESP was significantly attenuated, with the magnitude of potentiation being only 27 Ϯ 12% (n ϭ 5; Fig. 5B ). Taken together, these results suggest that PKC is involved in the phorbol ester-induced synaptic potentiation.
Involvement of Doc2␣-Munc13-1 interaction in phorbol ester-induced synaptic potentiation
We next examined the possibility that the Doc 2␣-Munc13-1 interaction (Orita et al., 1997) underlies the PESP. For this purpose, we injected into the calyx a synthetic peptide corresponding to the N-terminal domain of Doc 2␣, which interacts with Munc13-1 (the Mid domain: amino acid residues 13-37, see Materials and Methods). This Mid peptide alone blocks Doc 2␣-Munc13-1 interaction in vitro (Orita et al., 1997) and also blocks synaptic transmission when injected into presynaptic neurons in culture (Mochida et al., 1998) . In contrast, at the calyx of Held synapse, Mid peptide had no appreciable effect on EPSCs (Fig. 6 A) , with the amplitude of EPSCs remaining as 116 Ϯ 11% (n ϭ 7) 10 min after injection. However, in the presence of Mid, potentiation of EPSCs by PDBu was significantly attenuated in amplitude and no longer sustained (Fig. 6 A) . The magnitude of PESP 5 min after Mid application was 64 Ϯ 6.2% (n ϭ 7 vs 138 Ϯ Figure 4 . Phorbol ester had no effect on presynaptic potassium currents. Voltage-dependent K ϩ currents recorded from the caly x of Held in the presence of TTX. Potassium currents were evoked by a depolarizing pulse from Ϫ80 mV holding potential to 0 mV before and after PDBu application (superimposed in inset). The K ϩ current-voltage relationships before (E) and 5-7 min after (F) PDBu application. Data points and error bars derived from five calyces each. 29% in control, see above). As a control, we employed a mutated Mid peptide, which has no effect on Doc 2␣-Munc13-1 interaction (Mochida et al., 1998) . When the mutated Mid peptide was similarly loaded into calyces, PESP was not attenuated (124 Ϯ 15%; n ϭ 5; Fig. 6 B) .
DISCUSSION
At the brainstem auditory synapse formed by the caly x of Held, we have studied the facilitatory effect of phorbol ester on synaptic transmission. As reported previously (Malenka et al., 1986; Shapira et al., 1987; but see C aroll et al., 1998) , phorbol ester had no effect on the amplitude of spontaneous miniature EPSCs, confirming that the site of its action is predominantly presynaptic. Direct whole-cell recordings from the caly x of Held indicated that phorbol ester had no effect on presynaptic C a 2ϩ currents. It has been reported that phorbol ester has no effect on recombinant Ca 2ϩ channels containing ␣ 1A subunit, but enhances C a 2ϩ channels containing ␣ 1B subunit (Stea et al., 1995) . Since C a 2ϩ channels triggering transmitter release at the caly x of Held are predominantly P-type containing ␣ 1A subunits (Forsythe et al., 1998; Iwasaki and Takahashi, 1998) , possible involvement of N (␣ 1B ) type Ca 2ϩ channels in PESP at other synapses cannot be excluded from the present study (but see Yawo, 1999) . Our results also indicate that phorbol ester has no effect on presynaptic K ϩ currents. Thus, the mechanism for PESP must reside at the downstream of Ca 2ϩ influx as in secretory cells, where phorbol ester increases hormonal secretion without involving a change in intracellular Ca 2ϩ concentration (Gillis et al., 1996) . In chromaffin cells (Gillis et al., 1996) , retinal bipolar cells (Minami et al., 1998) , and hippocampal synapses in culture (Stevens and Sullivan 1998) , phorbol ester is postulated to increase the size of the releasable pool of synaptic vesicles by accelerating replenishment from a "reservoir pool" (but see Yawo, 1999) . What then might be the molecular target of phorbol esters? Diacylglycerol (DAG) and phorbol esters bind to the regulatory C 1 -domain of PKC and anchor the enzyme to the plasma membrane, thereby stabilizing its active conformation (Newton, 1997) . The phorbol ester-induced synaptic facilitation was attenuated by bath-application of PKC inhibitors BIS or calphostin C and also by the PKC inhibitory peptide directly injected into the calyx through whole-cell recording pipette. These results suggest that PKC is involved, at least in part, in the PESP. However, in spite of relatively high concentrations, the blocking effect of PKC inhibitors was incomplete, implying that there may be an additional mechanism mediating the effect of phorbol ester. While an involvement of PKC in the PESP has been suspected (Scholfield and Smith, 1989; Redman et al., 1997) , it was recently reported that phorbol esters or DAG stimulates the vesicular protein Doc2␣ to interact with the plasma membrane-associated protein Munc13-1 (Orita et al., 1997) . The N-terminal domain (Mid) of Doc2␣ is involved in this interaction. We have demonstrated that the synthetic Mid peptide introduced into the calyx of Held attenuates PESP. This effect appears specific since the mutated Mid peptide had no effect. Therefore, we conclude that the Doc2␣-Munc13-1 interaction is also involved in the PESP. In line with our results, it has been reported that presynaptic over-expression of Munc13-1 enhanced phorbol ester-dependent synaptic potentiation at Xenopus neuromuscular junctions in culture (Betz et al., 1998) .
Apart from interaction with Doc2␣, Munc13-1 can also interact with N-terminal of syntaxin 1, a SNARE protein thought to be involved in synaptic vesicle fusion (Betz et al., 1997) . On the other hand, PKC can phosphorylate another SNARE protein, SNAP-25 (Fujita et al., 1996; Shimazaki et al., 1996) , thereby stimulating catecholamine release from PC12 cells (Shimazaki et al., 1996) . Furthermore, PKC can phosphporylate Munc-18, which interacts with SNARE proteins. Thus the SNARE protein may be a common effector downstream of PKC and Munc13-1 for the phorbol ester-induced synaptic potentiation.
Munc13-1 is a mammalian homolog of C. elegans unc-13p and, by analogy, is thought to contribute to vesicle docking and exocytosis. In support of this hypothesis, Mochida et al. (1998) showed that Mid peptide blocked synaptic transmission when injected into the presynaptic neuron in culture. However, this effect was not observed at the calyx of Held, where the peptide was directly injected into the nerve terminal through patch pipette perfusion. Since the blocking effect of Mid at cultured synapses appears slow and activity-dependent (Mochida et al., 1998) , Munc13-1 might be involved in vesicular replenishing process rather than exocytotic process. It is also possible that exocytotic machineries are different between synapses. Figure 6 . Mid peptide attenuated PESP. A, Synthetic Mid peptide (Mid) had no effect on EPSCs (bottom sample records) evoked by presynaptic action potentials (top records) in simultaneous presynaptic and postsynaptic whole-cell recording at a caly x-M N TB synapse. Sample records were averaged from six events before ( a) and 5 min after ( b) Mid application, and 2 min ( c) and 18 min ( d) after PDBu application. B, Effect of PDBu on EPSCs at calyces loaded with Mid (F) or mutated Mid (E). Data derived from seven cells for Mid and five cells for mutated Mid. The difference was significant between Mid and mutated Mid and also between Mid and control ( Fig. 5B; E) , but not significant between the mutated Mid and control ( Fig. 5B ; E; one-way ANOVA).
